http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-9800985-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59aeacfc8c0fb15a69d7dd77723e2c36 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
| filingDate | 1998-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51e6b89ca0c9e7a7cd789f06e2e9f6c0 |
| publicationDate | 1999-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-9800985-A2 |
| titleOfInvention | Delayed release polymer blends for medical use |
| abstract | FIELD OF THE INVENTION The present invention relates to transdermal pharmaceutical compositions comprising 3- [4- (tert-butyl) -1,2,5-thiadiazol-3-yl] -1-azabicyclo [2.2.2] octane, which are 3- [ The amount of 4- (biphenyl) -1,2,5-thiadiazol-3-yl] -1-azabicyclo [2.2.2] octane needed to exert a therapeutic effect, a transdermal permeation agent, a gelling agent, moreover, they contain polishing agents such as ethanol, water and optionally propylene glycol. The present invention relates to a further method for the treatment of conditioners with modifying the muscarinic receptor potency by means of the above liver patch compositions. ŕ |
| priorityDate | 1997-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 231.